Rossari Biotech will list tomorrow but the grey market is already offering a premium of over 40%

• Rossari Biotech IPO was open for bidding between July 13-15, and it was oversubscribed by 79 times.
  
• A chemical manufacturing company based out of Mumbai, Rossari Biotech recently announced that it is hiring, stating that it is growing manifold and needs manpower.
  
• The Rossari Biotech IPO grey market premium is currently hovering above 40%, which suggests there could be a blockbuster listing on the cards.
  
• Check out the latest news and updates on Business Insider.

Rossari Biotech is all set to be listed on the bourses tomorrow, July 23. But even before the listing takes place, the grey market is already hot, with a premium of over 40%.

Rossari Biotech has an issue price of ₹425. However, the stock is already hot in the grey market. It is currently hovering in the range of ₹585-600, which suggests a grey market premium of up to ₹160-180 per share. This is an upside of over 40% over the issue price.


Rossari Biotech grey market premium – blockbuster listing on the cards?

Grey market premium is the measure of the extra amount that the market is ready to pay for a newly listed company’s share. It’s not an official measure, though, but it shows whether there is enough demand for a share in the market.

If the grey market premium on Rossari Biotech is anything to go by, the shares of the company could list at around ₹600, which is an upside of ₹175 over the issue price.

Overall, the Rossari Biotech IPO has been oversubscribed by 79 times, with non-institutional investors leading the charge, oversubscribing by almost 240 times.

Non-institutional investors are those who bid more than ₹2 lakh in an IPO.

SEE ALSO:

Rossari Biotech is hiring ⁠— and the company’s average salary is ₹10 lakh per year

Rossari Biotech IPO⁠ — 40 scientists, China, and other factors that make the share sale hot

Barbeque Nation IPO must be priced the same way as its menu —value for money